FIXED DOSE SHORT COURSE MITOMYCIN-C WITH VINCRISTINE IN ADVANCED PRE-TREATED BREAST-CANCER

被引：4
|
作者：
MILLWARD, MJ [1 ]
HENDRICK, A [1 ]
CANTWELL, BMJ [1 ]
机构：
[1] UNIV NEWCASTLE UPON TYNE,NEWCASTLE GEN HOSP,CTR REG RADIOTHERAPY,DEPT CLIN ONCOL,NEWCASTLE TYNE NE4 6BE,ENGLAND
来源：
ANNALS OF ONCOLOGY | 1990年 / 1卷 / 05期
关键词：
Breast cancer; Fixed dose mitomycin-C plus vincristin;
D O I：
10.1093/oxfordjournals.annonc.a057777
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：373 / 374
页数：2
相关论文
共 50 条
  • [21] Tolerability of mitomycin-C (MMC) and chronomodulated capecitabine (C) in pre-treated advanced colorecatal cancer (ACC) patients: preliminary results
    Campanella, Carla
    Garufi, Carlo
    Vanni, Barbara
    Calabretta, Francesca
    Torsello, Angela
    Aschelter, Anna Maria
    Bria, Emilio
    Cuppone, Federica
    Carlini, Paolo
    Terzoli, Edmondo
    ANNALS OF ONCOLOGY, 2004, 15 : 93 - 93
  • [22] MITOXANTRONE, MITOMYCIN-C AND VINCRISTINE COMBINATION CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC) REFRACTORY TO ANTHRACYCLIN
    BERGERAT, JP
    DUFOUR, P
    GIRON, G
    DUCLOS, B
    HERBRECHT, R
    LANG, JM
    OBERLING, F
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 120 - 120
  • [23] RANDOMIZED TRIAL OF DOXORUBICIN ALONE OR COMBINED WITH VINCRISTINE AND MITOMYCIN-C IN WOMEN WITH METASTATIC BREAST-CANCER
    INGLE, JN
    MAILLIARD, JA
    SCHAID, DJ
    KROOK, JE
    GERSTNER, JB
    PFEIFLE, DM
    MARSCHKE, RF
    LONG, HJ
    MCCORMACK, GW
    FOLEY, JF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (06): : 474 - 480
  • [24] EVALUATION OF HEXAMETHYLMELAMINE, CIS-DIAMMINEDICHLOROPLATINUM AND MITOMYCIN-C IN ADVANCED BREAST-CANCER
    LAWSON, DH
    MOORE, MR
    SMALLEY, RV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 369 - 369
  • [25] MYELOSUPPRESSION AFTER METHOTREXATE, MITOXANTRONE, AND MITOMYCIN-C FOR TREATMENT OF ADVANCED BREAST-CANCER
    MARKS, A
    GOODMAN, A
    DOUGHERTY, S
    ASHFORD, R
    LANCET, 1987, 1 (8538): : 915 - 915
  • [26] PROGESTIN (PN)-MITOMYCIN-C (MMC) SALVAGE THERAPY IN ADVANCED BREAST-CANCER
    FORMANEK, GA
    COHEN, FB
    LIPPMAN, AJ
    RUIZ, AM
    STEINBAUM, FL
    DECTER, JA
    CUSTODIO, MC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 411 - 411
  • [27] A RANDOMIZED TRIAL OF MITOMYCIN-C (M) VERSUS MITOMYCIN-C PLUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MMPA) IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, G
    FALKSON, CB
    FALKSON, HC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 14 - 17
  • [28] PHASE-II STUDY OF VINCRISTINE, MITOMYCIN-C AND MITOXANTRONE IN ADVANCED BREAST-CANCER - A PRELIMINARY-REPORT OF RESPONSE AND TOXICITY
    PERREN, TJ
    BLACKLEDGE, G
    MOULD, JJ
    CHETIYAWARDANA, AD
    MORRISON, M
    HANCOCK, A
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 173 - 177
  • [29] MITOMYCIN-C, VINCRISTINE, AND BLEOMYCIN THERAPY FOR ADVANCED CERVICAL-CANCER
    BAKER, LH
    OPIPARI, MI
    WILSON, H
    BOTTOMLEY, R
    COLTMAN, CA
    OBSTETRICS AND GYNECOLOGY, 1978, 52 (02): : 146 - 150
  • [30] ETOPOSIDE AND MITOMYCIN-C IN PRETREATED METASTATIC BREAST-CANCER
    MENICHETTI, ET
    SILVA, RR
    TUMMARELLO, D
    MISERIA, S
    TORRESI, U
    CELLERINO, R
    TUMORI, 1989, 75 (05) : 473 - 474
12345